4-1BB causes CAR-T cell death via sequestration of the ubiquitin-modifying enzyme A20
RNA-seq (gene expression) · human · 22 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 22 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE267821_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1113315 and SRA study SRP508555. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 22 samples.
How we read this: 8 replicated groups read from 22 sample titles; they account for 22 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8279283 CD19.CD28_Donor1 CD19.CD28_Dono
- GSM8279284 CD19.BB_Donor1 CD19.BB_Dono
- GSM8279285 CD19.BB.A20_Donor1 CD19.BB.A20_Dono
- GSM8279286 CD19.CD28.Ab activation_Donor1 CD19.CD28.Ab activation…
- GSM8279287 CD19.BB.Ab activation_Donor1 CD19.BB.Ab activation_D…
- GSM8279288 CD19.BB.A20.Ab activation_Donor1 CD19.BB.A20.Ab activati…
- GSM8279289 CD19.CD28_Donor2 CD19.CD28_Dono
- GSM8279290 CD19.BB_Donor2 CD19.BB_Dono
- GSM8279291 CD19.BB.A20_Donor2 CD19.BB.A20_Dono
- GSM8279292 CD19.BBdeltaC_Donor2 CD19.BBdeltaC_Dono
- GSM8279293 CD19.CD28.Ab activation_Donor2 CD19.CD28.Ab activation…
- GSM8279294 CD19.BB.Ab activation_Donor2 CD19.BB.Ab activation_D…
- GSM8279295 CD19.BB.A20.Ab activation_Donor2 CD19.BB.A20.Ab activati…
- GSM8279296 CD19.BBdeltaC.Ab activation_Donor2 CD19.BBdeltaC.Ab activa…
- GSM8279297 CD19.CD28_Donor3 CD19.CD28_Dono
- GSM8279298 CD19.BB_Donor3 CD19.BB_Dono
- GSM8279299 CD19.BB.A20_Donor3 CD19.BB.A20_Dono
- GSM8279300 CD19.BBdeltaC_Donor3 CD19.BBdeltaC_Dono
- GSM8279301 CD19.CD28.Ab activation_Donor3 CD19.CD28.Ab activation…
- GSM8279302 CD19.BB.Ab activation_Donor3 CD19.BB.Ab activation_D…
- GSM8279303 CD19.BB.A20.Ab activation_Donor3 CD19.BB.A20.Ab activati…
- GSM8279304 CD19.BBdeltaC.Ab activation_Donor3 CD19.BBdeltaC.Ab activa…
- GSE254547 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells 28 samples shares 4-1bb, car-t
- GSE276932 Gene expression in self-activating CAR-T cells with CD28 or 4-1BB costimulatory domain and G4S or Whilow218 linker. 15 samples shares 4-1bb, car-t
- GSE254546 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells to CD19.CD28.4-1BB CAR-T cells in vitro 12 samples shares 4-1bb, car-t
- GSE254544 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells in vitro 8 samples shares 4-1bb, car-t
- GSE254545 RNA sequencing comparison of B7-H3.TMIGD2 and B7-H3.CD28.4-1BB CAR-T cells in vivo. 8 samples shares 4-1bb, car-t
- GSE286827 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy 87 samples shares 4-1bb
- GSE302752 Safety, feasibility and pharmacodynamic activity of intratumoral injections of the agonist anti-CD137 (4-1BB) mAb urelumab in combination with nivolumab 76 samples shares 4-1bb
- GSE297676 Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single cell RNA sequencing 57 samples shares car-t
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.